Health
8 articles
Business
Brian McNamee, mere mortal
Because the CSL chair is so revered, nobody will say the quiet part out loud.
|
Business
The unravelling of CSL
The company is undisputed king of the blood products jungle no longer.
|
Business
CSL’s post-Perreault paroxysm
Our greatest biotech export is at the crossroads, or was it just t-boned?
|
Business
Pro Medicus pain alert
There is more soreness ahead for Australian investors who avoid the US radiology juggernaut.
|
Finance
Healthscope's problem was private equity
As the US experience demonstrates, PE and hospitals are a terrible mix.
|
Finance
Regal now blind and unfashionable
Phil King's clients are enduring one of their worst ever stints, but Rampart reckons you'd be mad to death-ride him.
|
Finance
Regal's Phil King plays a blinder
King has always been a shrewd risk manager, incredibly deft at placing his bets on a variety of colours and numbers before the ball goes. That's what's so surprising about this f— up.
|